Despite Guidelines, Some with Metastatic Colon Cancer Not Tested for Biomarkers

A retrospective study found that 40% of all patients with metastatic colon cancer are not tested according to guideline recommendations for biomarker testing.

Source: CancerNetwork - December 18, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news